Quality Certifications & Approvals

Comprehensive certifications and regulatory approvals demonstrating our commitment to quality and compliance in manufacturing Mefloquine Tablets USP 250mg.

Quality Management Certifications

WHO-GMP Certification

World Health Organization Good Manufacturing Practices

Certificate Details
  • Certificate Number: WHO-GMP/2023/089
  • Issue Date: March 15, 2023
  • Expiry Date: March 14, 2026
  • Issuing Authority: WHO Prequalification Team
  • Scope: Manufacturing of solid dosage forms
Key Features
  • Compliance with WHO GMP guidelines
  • Regular surveillance audits
  • Coverage of all manufacturing processes
  • International recognition

ISO 9001:2015

Quality Management System Certification

Certificate Details
  • Certificate Number: ISO-9001/2022/156
  • Issue Date: June 10, 2022
  • Expiry Date: June 9, 2025
  • Certification Body: SGS India
  • Scope: Manufacturing and supply of pharmaceutical products
Quality Management Features
  • Process-based quality management
  • Continuous improvement methodology
  • Customer satisfaction focus
  • Risk-based thinking approach

ISO 14001:2015

Environmental Management System Certification

Certificate Details
  • Certificate Number: ISO-14001/2022/089
  • Issue Date: August 22, 2022
  • Expiry Date: August 21, 2025
  • Certification Body: TÜV SÜD
  • Scope: Pharmaceutical manufacturing operations
Environmental Features
  • Environmental impact reduction
  • Waste management systems
  • Energy efficiency programs
  • Compliance with environmental regulations

OHSAS 18001:2007

Occupational Health & Safety Management System

Certificate Details
  • Certificate Number: OHSAS/2022/045
  • Issue Date: September 15, 2022
  • Expiry Date: September 14, 2025
  • Certification Body: Bureau Veritas
  • Scope: All manufacturing and office operations
Safety Management Features
  • Occupational health risk assessment
  • Safety training programs
  • Emergency response systems
  • Incident investigation procedures

Regulatory Approvals

US FDA Approval

United States Food and Drug Administration

Approval Details
  • Application Type: ANDA (Abbreviated New Drug Application)
  • Approval Date: January 12, 2023
  • Application Number: ANDA 215123
  • Product: Mefloquine Tablets USP 250mg
  • Applicant: Taj Pharmaceuticals Ltd.
Regulatory Features
  • Full compliance with US FDA cGMP
  • Approved for both treatment and prevention
  • Valid throughout the United States
  • Regular FDA inspections

EMA Approval

European Medicines Agency

Approval Details
  • Procedure: Decentralized Procedure
  • Approval Date: March 28, 2023
  • Authorization Number: EU/1/23/0456
  • Reference Member State: Germany
  • Concerned Member States: All EU member states
Regulatory Features
  • Valid throughout European Union
  • Compliance with EU GMP standards
  • Pharmacovigilance requirements met
  • Regular EMA inspections

WHO Prequalification

World Health Organization Prequalification Programme

Prequalification Details
  • PQ Number: PQ 2023/0123
  • Prequalification Date: February 15, 2023
  • Product: Mefloquine Tablets USP 250mg
  • Manufacturer: Taj Pharmaceuticals Ltd.
  • Facility: WHO-GMP certified manufacturing site
Prequalification Benefits
  • Eligible for UN procurement
  • Recognition by international agencies
  • Accelerated registration in many countries
  • Global quality assurance

International Certifications

Asia-Pacific

  • Japan PMDA: Approved (2022)
  • South Korea MFDS: Registered (2023)
  • Singapore HSA: Approved (2022)
  • Australia TGA: Listed (2023)
  • Thailand FDA: Registered (2022)

Africa

  • South Africa MCC: Registered (2022)
  • Nigeria NAFDAC: Approved (2023)
  • Kenya PPB: Registered (2022)
  • Ghana FDA: Approved (2023)
  • Egypt FDA: Registered (2022)

Americas

  • Canada Health: Approved (2023)
  • Brazil ANVISA: Registered (2022)
  • Mexico COFEPRIS: Approved (2023)
  • Argentina ANMAT: Registered (2022)
  • Chile ISP: Approved (2023)

Middle East

  • Saudi Arabia SFDA: Registered (2022)
  • UAE MOH: Approved (2023)
  • Israel MOH: Licensed (2022)
  • Jordan JFDA: Registered (2023)
  • Oman MOH: Approved (2022)

Certification Process

1

Application Preparation

Comprehensive documentation preparation including quality systems, manufacturing processes, and product specifications.

2

Facility Audit

On-site inspection by regulatory authorities to verify compliance with GMP and quality standards.

3

Documentation Review

Thorough review of all submitted documentation including quality manuals, SOPs, and validation reports.

4

Assessment & Decision

Comprehensive assessment of compliance and issuance of certification upon successful evaluation.

5

Surveillance & Renewal

Regular surveillance audits and renewal processes to maintain certification status.